公开(公告)号：US20190192597A1

公开(公告)日：2019-06-27

申请号：US15852748

申请日：2017-12-22

Applicant: Industrial Technology Research Institute

Inventor： I-Horng PAN ,  Hsin-Jan YAO ,  Chu-Hsun LU ,  Shu-Fang WEN ,  Po-Yao HSU ,  Ming-Han LI ,  Kai-An CHUANG ,  Chih-Hsuan CHANG

IPC: A61K36/287 ,  A61K9/00 ,  A61P17/06 ,  A61P17/04

CPC classification number: A61K36/287 ,  A61K9/0014 ,  A61K2236/19 ,  A61K2236/51 ,  A61K2236/53 ,  A61P17/04 ,  A61P17/06

Abstract: The present disclosure provides a method for preparing an extract of Chrysanthemum morifolium with an effect of treating skin diseases, including: (a) performing an extraction procedure on Chrysanthemum morifolium with an extraction solvent to obtain an extract solution; and (b) adding at least one glycoside hydrolases to the extract solution to make an enzyme reaction occur to produce a precipitate, wherein the precipitate is the extract of Chrysanthemum morifolium with an effect of treating skin diseases.

公开(公告)号：US20220339137A1

公开(公告)日：2022-10-27

申请号：US17860952

申请日：2022-07-08

Applicant: Industrial Technology Research Institute

Inventor： I-Hong PAN ,  Ming-Han LI ,  Kai-An CHUANG ,  Shu-Fang WEN

IPC: A61K31/353 ,  A61K9/00 ,  A61P17/06 ,  A61P29/00 ,  A61K9/06

Abstract: A composition for inhibiting skin cell proliferation and/or anti-inflammation is provided. The composition for inhibiting skin cell proliferation and/or anti-inflammation includes: apigenin and luteolin, wherein a weight ratio of the apigenin to the luteolin is about 1.5-25:1, or a mole ratio of the apigenin to the luteolin is about 1.5-25:1. Moreover, the apigenin and the luteolin have a synergistic effect on inhibiting skin cell proliferation and/or anti-inflammation.

公开(公告)号：US20150050315A1

公开(公告)日：2015-02-19

申请号：US14323719

申请日：2014-07-03

Applicant: Industrial Technology Research Institute

Inventor： I-Horng PAN ,  Shu-Fang WEN ,  Ming-Han LI ,  Hsin-Jan YAO ,  Hsin-Chieh WU ,  I-Huang LU ,  Joung-Liang LAN ,  Der-Yuan CHEN ,  Chi-Chien LIN ,  Ching LU

IPC: A61K36/07

CPC classification number: A61K36/07

Abstract: The disclosure provides a method for modulating Th17 cells, including: administering an Antrodia cinnamomea (also named Antrodia camphorata or Taiwanofungus camphoratus) extract to a subject in need thereof, wherein the Antrodia cinnamomea extract has an effect of modulating Th17 cells. The Antrodia cinnamomea extract may include a fruiting body extract of Antrodia cinnamomea or a mycelium extract of Antrodia cinnamomea.

Abstract translation: 本公开内容提供了一种调节Th17细胞的方法，包括：向有需要的受试者施用Antrodia cinnamomea（也称为樟芝或番茄樟脑）提取物，其中所述番茄红素提取物具有调节Th17细胞的作用。 梧桐提取物可以包括樟子松的果实提取物或肉桂樟子的菌丝体提取物。